PMID: 9169307Apr 1, 1997Paper

The effects of antidepressants on psychomotor function with particular reference to reboxetine

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
I Hindmarch

Abstract

This review assesses the relative efficacy and side-effect profile of the currently available treatment options for major depression and the new selective noradrenergic agent, reboxetine. The effects of these treatments on psychomotor function are reviewed using: choice reaction time (CRT) and critical flicker fusion threshold (CFFT) measurements to compare and contrast the various antidepressants. Tricyclic antidepressant (TCA) agents are associated with an increased risk of accidents, especially in the elderly (primarily accidents related to driving or falls/fractures due to postural hypotension). In comparison, the newer noradrenergic agents such as reboxetine have demonstrated significant improvements in the incidence and severity of effects on psychomotor function. Such a lack of side-effects makes agents like reboxetine most useful for the treatment of depression in ambulant patients performing their usual activities of daily living.

References

Jan 1, 1979·British Journal of Clinical Pharmacology·B Biehl
Nov 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·J ScottR Boys
Oct 1, 1992·American Journal of Epidemiology·W A RayM D Decker
Jan 1, 1992·Psychopharmacology·J Angst
Jan 1, 1992·European Journal of Clinical Pharmacology·J S KerrN Sherwood
Feb 12, 1987·The New England Journal of Medicine·W A RayL J Melton
Sep 1, 1980·British Journal of Clinical Pharmacology·I Hindmarch
May 6, 1982·The New England Journal of Medicine·D J GreenblattR I Shader
Oct 21, 1982·The New England Journal of Medicine
Mar 1, 1995·British Journal of Clinical Pharmacology·S R LordJ A Ward
Oct 1, 1994·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A J Silman
Apr 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·B E Leonard

❮ Previous
Next ❯

Citations

Sep 5, 2009·American Journal of Industrial Medicine·Donald C VoaklanderMichael L Wilson
Jan 1, 1999·International Journal of Psychiatry in Clinical Practice·M Quasim, A Kumar
Jul 23, 2003·Journal of Psychopharmacology·Wai S Tse, Alyson J Bond
Jan 13, 2006·Journal of Psychopharmacology·Dieuwke S VeldhuijzenEdmund R Volkerts
May 23, 2007·Clinical EEG and Neuroscience·Roland MerglUlrich Hegerl
Jul 20, 2002·Medicine and Science in Sports and Exercise·Maria Francesca PiacentiniKenny De Meirleir
Oct 31, 2002·Human Psychopharmacology·Alain Patat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacology and Therapeutics
I PoggesiJ C Fleishaker
Journal of Geriatric Psychiatry and Neurology
V AndreoliG Vantini
© 2021 Meta ULC. All rights reserved